About Index Trending news
Analyze
Pricing
Sanderling Ventures

Sanderling Ventures

Work at Sanderling Ventures? Add yourself to this profile

Sanderling Ventures

Sanderling has supported over 90 biomedical companies earning consistently high rates of return on its venture investments.

Elsewhere

Alexa global traffic share

Investment profile

Target markets
Health Care Biotechnology

Activity

Past year's investments

- Sanderling Ventures participated in 3 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $84,000,000 (averaging $28,000,000 per round).

Latest rounds

- PreciThera, Inc.: Venture capital (Series A) ($36M)
- PreciThera, Inc.: Venture capital (Series A) ($36M)
- Glycomine Inc.: Venture capital (Series A) ($12M)

Main Co-investors

- Intel Capital
- Mesa Verde Venture Partners
- Qualcomm Ventures

Total funding
$217.2M in 5 rounds from 14 investors
By Sanderling Ventures
$23.1M Series D in Feb, 2007
Total funding
$64M in 4 rounds from 13 investors
By Sanderling Ventures
$12.2M Series D in Dec, 2011
Total funding
$30.3M in 3 rounds from 16 investors
By Sanderling Ventures
$3.5M Series C in Dec, 2013
Total funding
$8M in 4 rounds from 7 investors
By Sanderling Ventures
$4M Venture capital in Jun, 2008
Total funding
$65M in 3 rounds from 15 investors
By Sanderling Ventures
$25M Series E in Jul, 2016
Exit Ethicon, Mar 27, 2017
Total funding
$56M in 3 rounds from 3 investors
By Sanderling Ventures
$21M Series D in Oct, 2010
Total funding
$44M in 1 rounds from 8 investors
By Sanderling Ventures
$44M Series C in Jan, 2007
Total funding
$100M in 1 rounds from 5 investors
By Sanderling Ventures
$100M Series B in Apr, 2016
Total funding
$12M in 1 rounds from 2 investors
By Sanderling Ventures
$12M Series A in Nov, 2016
Total funding
$72M in 2 rounds from 10 investors
By Sanderling Ventures
$36M Series A in Jul, 2017

Want to see the complete list?
Go Pro!